ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626167 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626167; 2) Community: the network communities that were significantly associated with the response to NSC 626167; 3) Molecule: the relationships between components within communities and NSC 626167; 4) MDR: the compounds that were significantly associated with the NSC 626167.

NSC Compound Enrichment Correlation
NSC 127755 Benzenesulfonyl fluoride, 3-chloro-4-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]butyl]-, monoethanesulfonate (9CI) 0.00744479268267747 0.2843361
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.00744479268267747 0.49239656
NSC 38643 Lenamycin 0.00744479268267747 0.39770925
NSC 58239 A 80021F34 0.00744479268267747 0.30345754
NSC 639186 Raltitrexed 0.00845932736945076 0.18438846
NSC 659162 1H-Benzimidazole, 5,5'-dithiobis[2-(trifluoromethyl)- (9CI) 0.00845932736945076 0.21483321
NSC 667911 Null 0.00845932736945076 0.067836053
NSC 675003 Benzofuran-3-carboxylic acid, 2,3-dihydro-7-hydroxy- 2-(3,4-dihydroxyphenyl)-5-(3-methoxy-3-oxo-1-propen-1-yl)-, methyl ester, stereoisomer 0.00845932736945076 0.028055222
NSC 681635 Camptothecin Derivative 0.00845932736945076 0.12304604
NSC 682881 Null 0.00845932736945076 0.2667954
Total:87  Current:21    [First] [Prev] [Next] [Last]